Point72 Asia (Singapore)’s Sage Therapeutics SAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$404K Buy
44,310
+21,477
+94% +$196K 0.07% 230
2025
Q1
$182K Buy
22,833
+2,192
+11% +$17.4K 0.05% 293
2024
Q4
$112K Buy
+20,641
New +$112K 0.03% 350
2024
Q3
Sell
-21,806
Closed -$237K 1270
2024
Q2
$237K Buy
21,806
+21,411
+5,421% +$233K 0.05% 257
2024
Q1
$7.4K Buy
+395
New +$7.4K ﹤0.01% 1013